|Articles|November 7, 2011
Hepatitis C Birth Cohort Screening is Cost-Effective
Advertisement
Birth cohort screening can be a cost-effective strategy to identify individuals infected with hepatitis C virus (HCV), according to a study published online Nov. 4 in the Annals of Internal Medicine.
Investigators from the National Opinion Research Center at the University of Chicago in Atlanta found that, compared to the current system, an additional 808,580 cases of chronic HCV were detected through birth cohort screening.
“Birth cohort screening for HCV in primary care settings was highly cost-effective,” the authors write.
Further details are available at:
Sources: HealthDay; MDNews.com
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
2
FDA Panel Backs 6 Peptides for Compounding
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Boston Panel Confronts Access and Coordination Gaps in Obesity Care
5